Darvoni a combination of Sofosbuvir 400 mg & Daclatasvir 60 mg for the Treatment of Hepatitis C will be commercially available from 7th January, 2016.
Sofosbuvir + Daclatasvir is strongly recommended by the AASLD
Box size: 6 tablets in a box
– USD 60 per box + Currier charge
For order and any information -please send mail to firstname.lastname@example.org
Darvoni Key points
– Shortest treatment duration irrespective of all genotypes
– High tolerability and safety profile
– High rate of SVR4 in difficult to treat patients infected by genotype1
– Ease of administration
– Recommended by AASLD and IDSA approved
Being a LDC country Bangladesh is a patent free country as per WTO. And under the “patient support program” we already send our #Daclavir (#Daclatasvir 60 mg) tablet, #Soforal (#Sofosbuvir 400 mg) tablet to more than 50 countries through direct shipping from our company.
Now we started sending #Darvoni (Sofosbuvir 400 + Daclatasvit 60 mg) tablet. We are able to send worldwide under our “patient support program”.
We have more than 60 cancer products. we started also sending under our “patient support program”.
All of your support encouraged us to extent our work.
Thanks to everybody.
To get reduce special price offer of our products like Darvoni , soforal, Daclavir. & for details please send mail to email@example.com
Source: Facebook page and group
1,748 total views, 5 views today